Synthesis and biological activity of new diazenedicarboxamides as potential anticancer agents

Area of Science:

• Medicinal Chemistry
• Oncology

Background:

• There is an urgent need for novel anti-cancer drugs and improved cancer treatment strategies.
• Previous research indicated that diazenes possess cytotoxic properties against tumor cells and can overcome resistance to existing chemotherapies like cisplatin and vincristine.
• Unsymmetrical diazenedicarboxamides 1 and 2 demonstrated significant cytotoxicity in prior studies.

Purpose of the Study:

• To synthesize novel N,N'-disubstituted diazenedicarboxamides with improved solubility and potent anti-cancer activity.
• To evaluate the biological efficacy of these newly synthesized compounds against various cancer types.
• To identify new potential anti-cancer agents for both primary and drug-resistant tumors.

Main Methods:

• Synthesis of a new series of N,N'-disubstituted diazenedicarboxamides.
• Biological evaluation of the synthesized compounds for cytotoxicity against different tumor cell lines.
• Structure-activity relationship analysis to identify key modifications for enhanced efficacy.

Main Results:

• Modification of previously identified compounds 1 and 2 resulted in more active anti-cancer agents.
• Diazenedicarboxamide 11 emerged as the most potent compound in the series.
• Compound 11 demonstrated significant cytotoxicity against a range of tumor types and exhibited efficacy against drug-resistant tumors.

Conclusions:

• The newly synthesized diazenedicarboxamides represent a promising class of anti-cancer agents.
• Diazenedicarboxamide 11 shows potential as a novel therapeutic candidate for diverse cancers, including those resistant to conventional treatments.
• Further development of diazenedicarboxamide 11 could lead to improved cancer treatment strategies.